nach oben

Erschienen in:

01.11.2011 | News item

Progestogen content of oral contraceptives singled out in VTE

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

According to a Danish study published in the BMJ, women using combined oral contraceptives (COCs) containing levonorgestrel have a threefold increased risk of experiencing venous thromboembolism (VTE), compared with non-users of hormonal contraception, while those using contraceptives containing desogestrel, gestodene or drospirenone have a six- to seven-fold increased risk.1 It is “unlikely that these findings could be explained by bias or confounding”, say the study's authors. …

Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E.Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9 BMJ 343: [15 pages], 25 Oct 2011. Available from: URL: http://dx.doi.org/10.1136/bmj.d6423

Hannaford PC.The progestogen content of combined oral contraceptives and venous thromboembolic risk. BMJ 343: [2 pages], 25 Oct 2011. Available from: URL: http://dx.doi.org/10.1136/bmj.d6592

Titel: Progestogen content of oral contraceptives singled out in VTE
Publikationsdatum: 01.11.2011
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201113760-00006

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Progestogen content of oral contraceptives singled out in VTE

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Isoflurane

Mivacurium chloride/sertraline interaction

Gimeracil/oteracil/tegafur

Tacrolimus

Bupropion

Interleukin-2